BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 4294770)

  • 1. Adrenergic neurone blocking activity of some new guanidine derivatives.
    Kadzielawa K; Gumulka W
    Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):287-96. PubMed ID: 4294770
    [No Abstract]   [Full Text] [Related]  

  • 2. The relation between the adrenergic neurone-blocking and noradrenaline-depleting actions of some guanidine derivatives.
    Abbs ET; Dodd MG
    Br J Pharmacol; 1974 Jun; 51(2):237-47. PubMed ID: 4451743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenergic neurone blocking agents of tropane and granatane structure. Their effect on the guinea pig vas deferens.
    Dóda M; Nádor K
    Acta Physiol Acad Sci Hung; 1967; 31(2):177-86. PubMed ID: 4295031
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationship between adrenergic neurone blocking activity and local anaesthetic activity in a series of guanidine derivatives.
    Rand MJ; Wilson J
    Eur J Pharmacol; 1967 May; 1(3):200-9. PubMed ID: 6069945
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of calcium on smooth muscles and on the adrenergic neuron blocking action of guanethidine.
    Chang CC; Lai FM; Chiueh CC
    Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):34-46. PubMed ID: 5102512
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tyramine and sympathetic transmission at the level of the deferens in the guinea pig].
    Della Bella D; Gandini A
    Pathol Biol; 1967 Feb; 15(3):172-9. PubMed ID: 4292967
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of cocaine, norepinephrine and ionic stimulants on the isolated, superfused rat vas deferens: antagonism by "adrenergic neuron blockers" and reserpine.
    Greenberg S; Long JP
    J Pharmacol Exp Ther; 1971 Apr; 177(1):136-45. PubMed ID: 5566758
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular studies of sympathetic denervation produced by 6-hydroxydopamine in the vas deferens.
    Furness JB; Campbell GR; Gillard SM; Malmfors T; Cobb JL; Burnstock G
    J Pharmacol Exp Ther; 1970 Jul; 174(1):111-22. PubMed ID: 4316531
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro interactions of the new anorexic agent WY-5244 with cardiac and vascular tissue and with adrenergic mechanisms.
    Baum T; Gluckman MI
    J Pharmacol Exp Ther; 1967 Dec; 158(3):510-8. PubMed ID: 5624080
    [No Abstract]   [Full Text] [Related]  

  • 10. Further studies on the adrenergic neuron blocking activity of some -adrenoceptor antagonists and guanethidine.
    Mylecharane EJ; Raper C
    J Pharm Pharmacol; 1973 Mar; 25(3):213-20. PubMed ID: 4146321
    [No Abstract]   [Full Text] [Related]  

  • 11. Ganglionic and adrenergic effects of 2-phenylquinoline methiodide analogues.
    Hitner H; Di Gregorio GJ; DiPalma JR; Gennaro A
    Arch Int Pharmacodyn Ther; 1973 Dec; 206(2):264-71. PubMed ID: 4360339
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta2-adrenoceptor-mediated prejunctional facilitation and postjunctional inhibition of sympathetic neuroeffector transmission in the guinea pig vas deferens.
    Todorov LD; Clerkin R; Mihaylova-Todorova ST; Khoyi MA; Westfall DP
    J Pharmacol Exp Ther; 2001 Aug; 298(2):623-33. PubMed ID: 11454924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of motor transmission in the vas deferens of the rat by adrenergic neuron blocking agents and beta-adrenoceptor blocking agents having local anaesthetic effects.
    Bourne RK
    J Pharm Pharmacol; 1974 May; 26(5):374-5. PubMed ID: 4152922
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence for the participation of a cholinergic receptor in adrenergic transmission.
    Lederer E; Rand MJ; Wilson J
    Arch Int Pharmacodyn Ther; 1970 May; 185(1):105-20. PubMed ID: 4319312
    [No Abstract]   [Full Text] [Related]  

  • 15. Prejunctional actions of some beta-adrenoreceptor antagonists in the vas deferens preparation of the guinea-pig.
    Mylecharane EJ; Raper C
    Br J Pharmacol; 1970 May; 39(1):128-38. PubMed ID: 4392958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of aralkylamines and aralkylguanidines as antagonists of adrenergic neurone blockade.
    Fielden R; Green AL
    J Pharm Pharmacol; 1966 Nov; 18(11):721-8. PubMed ID: 4382048
    [No Abstract]   [Full Text] [Related]  

  • 17. An analysis of the characteristics of the adrenergic neurone blocking action of dimethylphenylpiperazinium.
    Jayasundar S; Vohra MM
    Arch Int Pharmacodyn Ther; 1977 May; 227(1):23-9. PubMed ID: 901069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of prostaglandins on autonomic responses.
    Baum T; Shropshire AT
    Am J Physiol; 1971 Nov; 221(5):1470-5. PubMed ID: 4330893
    [No Abstract]   [Full Text] [Related]  

  • 19. The antagonism of adrenergic neurone blockade by amphetamine and dexamphetamine in the rat and guinea-pig.
    Follenfant MJ; Robson RD
    Br J Pharmacol; 1970 Apr; 38(4):792-801. PubMed ID: 5441791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission to the longitudinal muscle of the guinea-pig vas deferens: The effect of pretreatment with guanethidine.
    Furness JB
    Br J Pharmacol; 1974 Jan; 50(1):63-8. PubMed ID: 4150890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.